Effects of aggressive lipid-lowering therapy in patients with glomerulonephritis
Not Applicable
- Conditions
- glomerulonephritis
- Registration Number
- JPRN-UMIN000005392
- Lead Sponsor
- Division of Nephrology & Kidney Center, Kobe University School of Medicine.
- Brief Summary
At the time of remission of urinary protein, both groups showed a trend toward improvement in lipid abnormalities, but EL, which was not significantly different at the time of initiation of steroid therapy, remained higher in group A than in group C from the time of remission until 1 month later. After 3 months of remission, EL was similar in the two groups, but tended to be higher than at the beginning of treatment in both groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
1) Allergy against statins 2) Pregnant 3) Patients judged as being inappropriate for this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method